Obesity and Coronavirus Disease 2019

Obesity, which is one of the most important noncommunicable diseases, has become an epidemic. With the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, the collision of these two health risks has increased the threat of adverse events and serious threats to public health. In this review...

Full description

Saved in:
Bibliographic Details
Published inJournal of metabolic and bariatric surgery Vol. 10; no. 1; pp. 1 - 8
Main Authors Kim, Min-Ji, Jeon, Jae-Han
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Society for Metabolic and Bariatric Surgery 01.06.2021
Subjects
Review
Obesity
Angiotensin converting enzyme 2
Coronavirus disease 2019
Bariatric surgery
Online AccessGet full text

Cover

More Information
Summary:Obesity, which is one of the most important noncommunicable diseases, has become an epidemic. With the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, the collision of these two health risks has increased the threat of adverse events and serious threats to public health. In this review, the impact of obesity on COVID-19 severity and mortality is presented. The mechanism by which obesity increases susceptibility and severity is discussed. As a low-grade inflammatory disease, obesity provides a pro-inflammatory milieu by which adipose tissue expressing angiotensin converting enzyme 2, which is known as a receptor for severe acute respiratory syndrome coronavirus 2, works as a viral reservoir. Finally, the role of metabolic and bariatric surgeries during the COVID-19 era will be discussed.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2287-2930
2508-5956
DOI:10.17476/jmbs.2021.10.1.1